Showing results (121-130 of 156) with videos related to

Sort By:
Pageof 16
Journal of Molecular Biology|October 25, 2020
B cells from Patients with Rheumatoid Arthritis Show Conserved CD39-Mediated Regulatory Function and increased CD39 Expression After Positive Response to TherapyE R Zacca, M C Amezcua Vesely, P V Ferrero, et al.
The Journal of Antimicrobial Chemotherapy|April 14, 2009
Pegylated interferon {alpha}2a plus ribavirin versus pegylated interferon {alpha}2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patientsJ Berenguer, J González-García, J López-Aldeguer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 13, 2018
Inhibitory Receptor Expression on T Cells as a Marker of Disease Activity and Target to Regulate Effector Cellular Responses in Rheumatoid ArthritisLuisina I Onofrio, Estefania R Zacca, Paola Ferrero, et al.
Revista De Neurologia|January 29, 2011
[HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system]J J Merino, M L Montes, A Blanco, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 27, 2005
Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study)José R Arribas, Federico Pulido, Rafael Delgado, et al.
HIV Medicine|May 17, 2023
Three-year efficacy of switching to dolutegravir plus lamivudine: A real-world studyE Palmier, R De Miguel, R Montejano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2014
A prospective cohort study of neurocognitive function in aviremic HIV-infected patients treated with 1 or 3 antiretroviralsIgnacio Pérez-Valero, Alicia González-Baeza, Miriam Estébanez, et al.
The Journal of Infectious Diseases|April 1, 2024
Mitochondrial Haplogroups and Weight Gain After Initiating ART in Patients With HIVJuan Berenguer, Inmaculada Jarrín, José M Bellón, et al.
Plos One|August 13, 2013
Neurocognitive impairment in patients treated with protease inhibitor monotherapy or triple drug antiretroviral therapyIgnacio Pérez-Valero, Alicia González-Baeza, Miriam Estébanez, et al.
AIDS (London, England)|March 5, 2019
Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV/hepatitis C virus coinfected individualsJuan Berenguer, Ángela Gil-Martin, Inmaculada Jarrin, et al.
Pageof 16